Status of drug resistance in tuberculosis after the introduction of rifampicin in India

Journal of the Indian Medical Association

Volumn 101, Issue 3, 2003, Pages 154-156

  Paramasivan, C N ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Drug resistance; Multidrug resistant tuberculosis (MDR TB); Prevalence

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ESTONIA; HEALTH EDUCATION; HUMAN; INDIA; MULTIDRUG RESISTANCE; PREVALENCE; SHORT SURVEY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0042818081     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. WHO - WHO/IUATLD Global Project on Antituberculosis Drug Resistance Surveillance: Antituberculosis drug resistance in the world. Report No 2. Geneva: WHO, 2000: WHO/CDS/TB/2000.278.
2. World Health Organization - WHO/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance: guidelines for surveillance of drug resistance in tuberculosis. Geneva: WHO, 1997: WHO/TB/96.216
3. Paramasivan CN - An overview of drug resistant tuberculosis in India. Indian J tuberc 1998; 45: 73-81.
4. Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanam NM, Prabhakar R - Bacteriological investigations for short course chemotherapy under the tuberculosis control programme in two districts of India. Tuberc Lung Dis 1993; 74: 23-37.
5. Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekaran V, Narayanan PR - Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000; 47: 27-33.
6. Paramasivan CN, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan PR - Surveillance of drug resistance in two districts of South India. Int J Tuberc Lung Dis 2002; 6: 479-84.
7. Datta M, Radhamani MP, Selvaraj R, Paramasivan CN, Gopalan BN, Sudeendra CR, et al - Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuberc Lung Dis 1993; 74: 180-6.